Literature DB >> 11767308

Improved high-performance liquid chromatographic method to estimate aminosugars and its application to glycosaminoglycan determination in plasma and serum.

G M Campo1, S Campo, A M Ferlazzo, R Vinci, A Calatroni.   

Abstract

An improved isocratic high-performance liquid chromatography (HPLC) method for the analysis of L-(-)-fucose. D-(+)-galactosamine, D-(+)-glucosamine, D-(+)-galactose, obtained by hydrolysis of glycosaminoglycans (GAGs) and D-(+)-glucose and D-(+)-mannose is described. The presence in circulation of GAGs, acid polysaccharide sequences of alternate monosaccharide units, aminosugar and uronic acid (galactose in keratan sulfate), has been measured in terms of their sugar components. To evaluate concentration of these circulating sugars we considered blood samples obtained from healthy humans. Plasma or serum was filtered through weak anion-exchange Ecteola-cellulose either untreated or after mild alkaline treatment. GAGs adhering to resin were recovered by salt elution, and desalted on Bio-Gel P-2 resin. GAG fractionation by charge was carried out on a strong anion exchanger. GAG composition was evaluated in terms of galactose and aminosugars, measured in HPLC by the proposed procedure using anion-exchange resin and pulsed amperometric detection. The mobile phase consisted of 0.02 M NaOH and elution was carried out at flow-rate of 1.0 ml/min. The amperometric detector was set as follows: t1 (0.5 s), E1 (+0.1 V); t2 (0.09 s), E2 (+0.6 V); t3 (0.05 s), E3 (-0.6 V). The analysis required 14 min. Calibration standard curves for the six analytes were linear from 0.25 to 40 microM. RSD values for intra- and inter-day variabilities were < or = 5.3% at concentrations between 0.25 and 40 microM. Accuracy, expressed as percentage error, ranged from - 16 to 14%. The method was specific and sensitive with quantitation limits of 1 pmol for L-(-)-fucose, D-galactosamine and D-glucosamine, 3 pmol for D-(+)-galactose and D-(+)-glucose and 5 pmol for D-(+)-mannose. The results of the assay showed higher GAG concentrations in serum than in plasma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11767308     DOI: 10.1016/s0378-4347(01)00427-3

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  8 in total

1.  Characterization of serum 'glycosaminoglycan (GAG) chains' and 'native proteoglycan' fractions in the ostrich.

Authors:  A M Ferlazzo; G M Campo; P Medica; A Calatroni
Journal:  Vet Res Commun       Date:  2003-09       Impact factor: 2.459

2.  The Quantification of Glycosaminoglycans: A Comparison of HPLC, Carbazole, and Alcian Blue Methods.

Authors:  Sarah B Frazier; Kevin A Roodhouse; Dennis E Hourcade; Lijuan Zhang
Journal:  Open Glycosci       Date:  2008-01-01

Review 3.  Recent advances in biotechnology for heparin and heparan sulfate analysis.

Authors:  Meng Qiao; Lei Lin; Ke Xia; Jun Li; Xing Zhang; Robert J Linhardt
Journal:  Talanta       Date:  2020-06-14       Impact factor: 6.057

Review 4.  Hyphenated techniques for the analysis of heparin and heparan sulfate.

Authors:  Bo Yang; Kemal Solakyildirim; Yuqing Chang; Robert J Linhardt
Journal:  Anal Bioanal Chem       Date:  2010-09-19       Impact factor: 4.142

Review 5.  Advances in glycosaminoglycan detection.

Authors:  Shaukat A Khan; Robert W Mason; Hironori Kobayashi; Seiji Yamaguchi; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2020-03-27       Impact factor: 4.797

6.  Structural analysis and biosynthesis gene cluster of an antigenic glycopeptidolipid from Mycobacterium intracellulare.

Authors:  Nagatoshi Fujiwara; Noboru Nakata; Takashi Naka; Ikuya Yano; Matsumi Doe; Delphi Chatterjee; Michael McNeil; Patrick J Brennan; Kazuo Kobayashi; Masahiko Makino; Sohkichi Matsumoto; Hisashi Ogura; Shinji Maeda
Journal:  J Bacteriol       Date:  2008-03-07       Impact factor: 3.490

7.  Efficacy of treatment with glycosaminoglycans on experimental collagen-induced arthritis in rats.

Authors:  Giuseppe M Campo; Angela Avenoso; Salvatore Campo; Alida M Ferlazzo; Domenica Altavilla; Alberto Calatroni
Journal:  Arthritis Res Ther       Date:  2003-03-06       Impact factor: 5.156

8.  Glycosaminoglycans from Co-Products of «Scyliorhinus canicula»: Extraction and Purification in Reference to the European Pharmacopoeia Requirement.

Authors:  Nawras Talmoudi; Noureddine Ghariani; Saloua Sadok
Journal:  Biol Proced Online       Date:  2020-01-02       Impact factor: 3.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.